<DOC>
	<DOCNO>NCT02350114</DOCNO>
	<brief_summary>This observational study functional capacity patient Heart failure Reduced Ejection Fraction ( HFrEF ) admit hospital routine medical treatment .</brief_summary>
	<brief_title>An Observational Study Functional Capacity Heart Failure</brief_title>
	<detailed_description>This observational study evaluate functional capacity ( ability walk distance walk ) patient Heart failure Reduced Ejection Fraction ( HFrEF ) approximately 50-70 patient present Acute Heart Failure approximately 5-6 hospital site USA . All enrol patient evaluated baseline functional capacity . Patients receive standard Acute Heart Failure therapy serially assess change functional capacity .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Have leave ventricular ejection fraction ( LVEF ) â‰¤40 % , assess method , e.g. , echocardiography , multigated acquisition ( MUGA ) scan magnetic resonance imaging ( MRI ) ; Present sign symptom consider primarily due AHF admit hospital AHF ; Confirmation verbally patient ambulatory , i.e. , able walk &gt; 30m , prior develop symptom AHF lead current admission ; Be capable understanding nature trial ; willing able comply inpatient outpatient study protocol requirement duration study ; willing participate , document write informed consent . Have systolic blood pressure &lt; 90mmHg &gt; 170mmHg baseline ; Have anticipate need invasive procedure within 3 day study enrollment , e.g. , due hemodynamic cardiac rhythm instability , acute coronary syndrome , require procedure include , limited , cardiac catheterization , placement defibrillator/pacemaker , placement pulmonary artery catheter ; Have primary HF etiology attributable either restrictive/obstructive cardiomyopathy , idiopathic hypertrophic cardiomyopathy ( define wall thickness &gt; 1.8cm ) obstructive , uncorrected severe valvular disease ( except mitral regurgitation ) ; Have comorbidities limit ambulation patient 's heart failure , e.g. , symptomatic peripheral arterial disease , COPD , arthritis condition , confirm verbally patient ; Have severe renal insufficiency ( define GFR &lt; 30mL/min/1.73m2 accord MDRD equation ) ; Have anticipate survival le 90 day , reason ; Have receive investigational agent ( drug , device biologic product ) within 30 day ( , longer , 5 halflives drug biologic agent ) prior study entry , plan receive investigational agent time throughout full duration study least Study Day 35 ; Have clinically significant laboratory abnormality , medical condition social circumstance , investigator 's opinion , make inappropriate patient participate clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>6 Minute Walk Test</keyword>
</DOC>